BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6849503)

  • 1. Is theophylline, aminophylline, or caffeine (methylxanthines) contraindicated in malignant hyperthermia susceptible patients?
    Flewellen EH; Nelson TE
    Anesth Analg; 1983 Jan; 62(1):115-8. PubMed ID: 6849503
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro contracture tests for susceptibility to malignant hyperthermia.
    Rosenberg H; Reed S
    Anesth Analg; 1983 Apr; 62(4):415-20. PubMed ID: 6829945
    [No Abstract]   [Full Text] [Related]  

  • 3. [Contracture response to isoflurane and pentazocine in muscles of a patient with malignant hyperthermia].
    Iwatsuki N; Shiratori T; Fudeta H; Shiozawa S; Amaha K
    Masui; 1986 Mar; 35(3):468-72. PubMed ID: 3712745
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of chlorocresol vs caffeine on muscle contracture in malignant hyperthermia susceptible patients].
    Ben-Abraham R; Krivosic-Horber RM; Haudcoeur G; Perel A; Adnet PJ
    Harefuah; 1997 Jun; 132(12):839-41, 911. PubMed ID: 9264187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant hyperthermia and related neuromuscular diseases: caffeine contracture of the skinned muscle fibers.
    Takagi A; Sunohara N; Ishihara T; Nonaka I; Sugita H
    Muscle Nerve; 1983 Sep; 6(7):510-4. PubMed ID: 6633564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety considerations for patients with epilepsy taking antiepileptic drugs alongside caffeine or other methylxanthine derivatives.
    Chrościńska-Krawczyk M; Radzik I; Miziak B; Czuczwar SJ
    Expert Opin Drug Metab Toxicol; 2014 Jul; 10(7):981-9. PubMed ID: 24848690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant hyperthermia.
    Sessler DI
    Acta Anaesthesiol Scand Suppl; 1996; 109():25-30. PubMed ID: 8901933
    [No Abstract]   [Full Text] [Related]  

  • 8. Human malignant hyperthermia: awake episodes and correction by dantrolene.
    Gronert GA; Thompson RL; Onofrio BM
    Anesth Analg; 1980 May; 59(5):377-8. PubMed ID: 7189384
    [No Abstract]   [Full Text] [Related]  

  • 9. The Israeli Diagnostic Center for Malignant Hyperthermia: 7-years' accumulated experience.
    Glauber V; Ben Abraham R; Zweig A; Perel A
    Isr J Med Sci; 1997 Oct; 33(10):643-7. PubMed ID: 9397136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of neuroleptic malignant syndrome: in vitro muscle comparison with malignant hyperthermia.
    Tollefson G
    J Clin Psychopharmacol; 1982 Aug; 2(4):266-70. PubMed ID: 6126494
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of droperidol, haloperidol and ketamine on halothane, succinylcholine and caffeine contractures: implications for malignant hyperthermia.
    Fletcher JE; Rosenberg H; Lizzo FH
    Acta Anaesthesiol Scand; 1989 Apr; 33(3):187-92. PubMed ID: 2728821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanical properties of normal and malignant hyperthemia susceptible porcine muscle: effects of halothane and other drugs.
    Gallant EM; Godt RE; Gronert GA
    J Pharmacol Exp Ther; 1980 Apr; 213(1):91-6. PubMed ID: 6965721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fulminant malignant hyperthermia.
    Bross T; Steinmann D
    Acta Anaesthesiol Scand; 2008 Jan; 52(1):164-5. PubMed ID: 18173438
    [No Abstract]   [Full Text] [Related]  

  • 14. Halothane-succinylcholine induced masseter spasm: indicative of malignant hyperthermia susceptibility?
    Flewellen EH; Nelson TE
    Anesth Analg; 1984 Jul; 63(7):693-7. PubMed ID: 6731899
    [No Abstract]   [Full Text] [Related]  

  • 15. [Malignant hyperthermia-results of familial investigations in Austria (author's transl)].
    Sporn P
    Wien Klin Wochenschr Suppl; 1981; 132():1-28. PubMed ID: 6952655
    [No Abstract]   [Full Text] [Related]  

  • 16. [Theophylline induces contractures in porcine skeletal muscle preparations with the disposition to malignant hyperthermia].
    Gerbershagen MU; Fiege M; Weisshorn R; Kolodzie K; Wappler F
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Mar; 39(3):147-52. PubMed ID: 15042504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central core disease and malignant hyperthermia syndrome.
    Frank JP; Harati Y; Butler IJ; Nelson TE; Scott CI
    Ann Neurol; 1980 Jan; 7(1):11-7. PubMed ID: 7362206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for malignant hyperthermia susceptibility.
    Anderson IL; Rawstron RE; Dunlop DJ
    N Z Med J; 1980 Jun; 91(661):417-9. PubMed ID: 6930029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant hyperthermia in China.
    Xu ZH; Luo AL; Guo XY; Ren HZ; Wang YL; Zhang X; Huang YG; Ye TH
    Anesth Analg; 2006 Oct; 103(4):983-5. PubMed ID: 17000816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Contracture responses of the muscle from a patient with malignant hyperthermia to drugs].
    Iwatsuki N; Koga Y; Amaha K
    Masui; 1984 Jul; 33(7):731-6. PubMed ID: 6502923
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.